Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Meta-analysis reveals glaucoma as a risk factor for Alzheimer’s disease
  • Glaucoma

Meta-analysis reveals glaucoma as a risk factor for Alzheimer’s disease

Kelsey Moroz

Individuals with glaucoma are at a significantly higher risk of developing Alzheimer’s disease (AD), according to a new meta-analysis.

The study, which evaluated data from 8 articles involving a total of 131,987 participants published, focused on assessing the risk of AD events in individuals diagnosed with glaucoma.

The analysis demonstrated a combined hazard ratio of 1.29 (95% confidence interval = 1.05-1.59; P < .001; I² = 95.1%), indicating that glaucoma patients exhibit a significantly higher risk for disease-free survival in AD cases. Subgroup analyses identified normal tension glaucoma as the predominant risk factor contributing to this increased risk.

These findings suggest that individuals with glaucoma should be monitored closely for potential AD symptoms.

Reference
Jiang M, Wang X, Liu Y, et al. Association between glaucoma and the risk of Alzheimer’s disease: A meta-analysis. Medicine (Baltimore). 2024;103(40):e39897. doi: 10.1097/MD.0000000000039897. PMID: 39465755.

Share

Related Content

  • Glaucoma

Large wearable study examines physical activity and sleep in adults with glaucoma

  • Glaucoma

Optometrists expand role in glaucoma care worldwide, but barriers remain

  • Glaucoma

Global glaucoma disability rates decline despite rising case burden

  • Glaucoma

Adults with ASD show higher rates of glaucoma, cataract, and other eye conditions

  • Glaucoma

Cognitive function and comorbidity linked to different glaucoma medication adherence barriers

  • Glaucoma

AOA 2026: Surgical and technological advances to improve quality of life and reduce drop burden in glaucoma

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon